Neptune Medical

What Neptune Medical does

Neptune Medical is a venture-backed medical device company headquartered in Burlingame, California, that designs, manufactures, and commercializes devices built on its proprietary Dynamic Rigidization™ technology. The core platform uses vacuum-activated microcomposite layers within thin-walled tubes to toggle them between flexible and rigid states on demand, achieving up to a 15x change in stiffness without foreshortening or shape change. This technology foundation is protected by three issued US patents (US 11,135,398; US 11,554,248; US 11,744,443) and multiple pending applications, with trademarks registered for Dynamic Rigidization™ and Pathfinder™.

The company's commercial portfolio is anchored by the FDA-cleared Pathfinder® overtube, a single-use disposable device that prevents scope looping and provides 1:1 tip control during diagnostic and therapeutic GI endoscopy procedures including colonoscopy, enteroscopy, ERCP, ESD, and polypectomy. Pathfinder CR, an accessory launched in October 2024, extends the platform to upper GI bleeding management. Neptune Medical is also developing the investigational Triton Robotic Endoscopy System, which demonstrated a 100% cecal intubation rate, 0% adverse events, a 54.2% adenoma detection rate, and a 67% reduction in ergonomic burden for endoscopists in a 50-patient first-in-human CARE 1 study conducted in Poland.

Neptune Medical generates revenue from hardware sales of single-use Pathfinder devices through a direct enterprise field-sales motion targeting gastroenterologists and hospital GI departments at leading U.S. academic medical centers; no capital equipment purchase is required from customers, lowering adoption friction. The company employs 101-250 people and has raised approximately $97 million in a 2024 Series D round led by Sonder Capital with participation from Olympus. The company has spun out Jupiter Endovascular as a separately capitalized entity to pursue non-GI applications of the same Dynamic Rigidization platform.

Name

Neptune Medical

Legal name

Neptune Medical

Website

https://gipathfinder.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

101–250 employees

Short description

Neptune Medical is a venture-backed medical device company developing GI endoscopy devices based on its proprietary Dynamic Rigidization™ technology. It sells the FDA-cleared Pathfinder overtube directly to U.S. hospitals and is developing the investigational Triton robotic endoscopy system.

Ownership category

akta.pro rank

Product category

GI Endoscopy Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB)

akta.pro secondary industries

Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM), Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN), Advanced Endoscopy (ERCP/EUS/Interventional) (HLAKAEAC)

Keywords

• Endoscopy overtube devices
• GI endoscopy equipment
• Robotic colonoscopy systems
• Dynamic rigidization technology
• Medical device manufacturing

Headquarters

HQ city

Burlingame

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales

Revenue model

1. Pathfinder Device Sales: Neptune Medical generates revenue from the sale of its FDA-cleared Pathfinder dynamic rigidizing overtube. The device is a single-use disposable product, creating recurring revenue from procedure volume. No capital equipment purchase is required from customers, lowering adoption barriers.
2. Triton System (Future): The Triton Robotic Endoscopy system is currently investigational and not yet authorized for sale. Future revenue stream anticipated upon regulatory clearance.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Neptune Medical designs, manufactures, and commercializes medical devices built on its proprietary Dynamic Rigidization™ technology, which uses vacuum activation to instantly toggle thin-walled tubes between flexible and rigid states. Its commercial flagship is the FDA-cleared Pathfinder® overtube, a single-use disposable device that prevents looping and provides 1:1 endoscope tip control during GI procedures such as colonoscopy, enteroscopy, and ERCP. The portfolio is extended by the Pathfinder® CR accessory for upper GI bleeding and the investigational Triton Robotic Endoscopy System.

Product overview

Neptune Medical develops medical devices based on proprietary Dynamic Rigidization technology that enables thin-walled tubes to toggle between flexible and rigid states. The product portfolio includes the FDA-cleared Pathfinder overtube (core product) for loop prevention in GI endoscopy, the Pathfinder CR accessory for upper GI bleeding management, and the investigational Triton Robotic Endoscopy System for robotic colonoscopy. The Dynamic Rigidization technology uses vacuum activation to achieve up to 15x change in stiffness without foreshortening or shape change.

Differentiator

Problem solved

Functional benefit

Brands

• Pathfinder: FDA-cleared dynamic rigidizing overtube for GI endoscopy stability that toggles from flexible to rigid to prevent looping during colonoscopy and other GI procedures.
• Pathfinder CR
• Triton Robotic Endoscopy System

Products and services

• Pathfinder® Dynamic Rigidizing Overtube FDA-cleared, single-use dynamic rigidizing overtube that instantly toggles from flexible to rigid using vacuum-activated technology. Used by gastroenterologists in colonoscopy, enteroscopy, ERCP, ESD, EMR, and polypectomy to prevent looping, enable 1:1 tip control, support easy scope swapping, and reduce physical burden on endoscopists. Sold to hospitals and academic medical centers with no capital equipment required.
• Pathfinder® CR (Upper GI Bleed Accessory) Accessory for the Pathfinder overtube designed for upper GI bleeding management. Provides powerful suction, efficient clot removal, on-demand suction control via foot pedal, and improved visibility to rapidly address and treat upper GI hemorrhaging during endoscopy.
• Triton Robotic Endoscopy System Investigational robotic colonoscopy system designed to address increasing colonoscopy demands. Demonstrated 100% cecal intubation rate, 0% adverse events, and 54.2% adenoma detection rate in a 50-patient first-in-human study conducted at H-T Centrum Medyczne in Tychy, Poland. Currently investigational and not yet authorized for sale.

Quantifiable outcome

• 100% cecal intubation success rate in 50-patient first-in-human study
• +8 more outcomes

Named customers6 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• NVIDIAstrategicTechnology or Integration · 18 March 2025Neptune Medical is an early adopter evaluating or integrating NVIDIA's Isaac for Healthcare platform, an AI-powered medical robotics development framework that leverages MONAI for pretrained models, NVIDIA Omniverse for simulation, and NVIDIA Holoscan for on-robot deployment. This supports development of AI-driven robotic systems.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Olympus Corporation: Dominant incumbent in GI endoscopy systems and accessories; also a Series D investor in Neptune. Competes with Pathfinder via traditional overtubes and therapeutic endoscopes and would be the most likely strategic acquirer of Triton-class technology.
• Boston Scientific: Major endoscopy and endotherapy portfolio (single-use devices, hemostasis tools, ERCP accessories). Directly comparable as a competitor in single-use GI therapeutic devices and a likely M&A counterparty for Neptune's endotherapy platform.
• Intuitive Surgical: Dominant robotic surgery platform (da Vinci) and a benchmark for what a successful robotic endoscopy franchise could look like at scale. Dr. Fred Moll, its co-founder, is a Neptune investor, linking the two commercially and strategically.
• Pentax Medical (HOYA): Global GI endoscopy system and accessory manufacturer. Comparable as a competitor for endoscopic overtubes, ERCP accessories, and capital endoscopy platforms targeted by Neptune.
• Fujifilm Healthcare: GI endoscopy systems and single-use accessories competitor. Overlaps with Neptune on endotherapy accessories and colonoscopy consumables where Pathfinder competes.
• Steris (US Endoscopy): Owner of US Endoscopy and a broad portfolio of GI therapeutic accessories. Directly competes with Pathfinder and Pathfinder CR in endotherapy consumables and hemostasis devices.

Direct peers

• Ambu A/S: Single-use endoscope pioneer with rapid adoption in GI and pulmonary endoscopy. Closely comparable business model to Neptune's single-use, no-capital-equipment disposable strategy.

Emerging players

• EndoQuest Robotics: Emerging robotic endoscopy developer pursuing flexible robotic platforms for GI procedures. Most direct emerging competitor to Neptune's Triton robotic colonoscopy program.
• Endiatx: Developer of a robotic pill endoscope for diagnostic colonoscopy. Adjacent emerging competitor exploring automation of GI endoscopy, sharing Triton's long-term vision.

Others

• Jupiter Endovascular: Sister company spun out of Neptune Medical, applying Dynamic Rigidization technology to endovascular applications. Demonstrates platform extensibility and is a relevant comparable for valuation of the broader technology platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xtwitter.com/GIPathfinder
• Facebookfacebook.com/GIPathfinder
• LinkedInlinkedin.com/company/neptunemedical
• Instagraminstagram.com/gipathfinder

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds3 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neptune Medical